Lionco Pharm Grp Co Ltd (603669.SS) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE1000022R8
Lionco Pharm Grp Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 379.78 m CNY | 322.48 m CNY |
| Gross profit | 173.26 m CNY | 140.97 m CNY |
| Operating income | -128.77 m CNY | -93.26 m CNY |
| EBIT | -100.28 m CNY | -172.32 m CNY |
| Net income | -130.76 m CNY | -193.24 m CNY |
| Diluted EPS – continuing operations | -0.18 CNY | -0.27 CNY |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Lionco Pharm Grp Co Ltd
Lionco Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products and medical services in China. It offers chemical and prescription drugs for nutrition, antimicrobial, antiviral, digestive, cardiovascular, cerebrovascular, detoxification, anti-tumor, anti-infective drugs, and other applications. Lionco Pharmaceutical Group Co.,Ltd. was founded in 2003 and is based in Shannan, China.
More stocks
- Jiangsu Province Commun (603018.SS)
- Fuller Smith & Turner PLC (FSTA.L)
- WPG (Shanghai) Smart Water Public Co. Ltd (603956.SS)
- Advanced Wireless Semiconductor Co (8086.TWO)
- Jiangsu Beiren Robot System Co Ltd (688218.SS)
- Beijing Navigation Control Technology Co. Ltd. (688282.SS)
- Artea bankas AB (ROE1L.VS)
- Huarong Chemical Co. Ltd. (301256.SZ)
- Blumar (BLUMAR.SN)
- Sparebanken More (MORG.OL)
- Bally's Corp (BALY)
- SMU S.A (SMU.SN)
Not investment advice. All data without warranty, price as of 06.11.2026. Details in the risk notice.